AMJEVITA Trademark

Trademark Overview


On Wednesday, December 11, 2019, a trademark application was filed for AMJEVITA with the United States Patent and Trademark Office. The USPTO has given the AMJEVITA trademark a serial number of 88723059. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Saturday, November 21, 2020. This trademark is owned by Amgen Inc.. The AMJEVITA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations, substances and biosimilars used for the treatment of bone, joint, intestine, colon, skin, lung, eye, bladder, blood cells, and blood vessel diseases and disorders; pharmaceutical preparations, substances and biosimilars for the treatment of autoimmune and immune system, inflammatory, inflammatory bowel, gastrointestinal, musculoskeletal, dermatological, pulmonary, respiratory, oncological, and ophthalmic diseases and disorders; pharmaceutical preparations, substances and biosimilars used for the treatment of arthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, juvenile idiopathic arthritis, enthesitis related arthritis, osteoarthritis, peripheral spondyloarthritis, acute disc prolapse, inflammatory bowel disease, Crohn's disease, ulcerative colitis, Intestinal Behçet's Disease, chronic pouchitis, small bowel lesions, Hermansky-Pudlak syndrome, psoriasis, psoriasis vulgar...
amjevita

General Information


Serial Number88723059
Word MarkAMJEVITA
Filing DateWednesday, December 11, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateSaturday, November 21, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations, substances and biosimilars used for the treatment of bone, joint, intestine, colon, skin, lung, eye, bladder, blood cells, and blood vessel diseases and disorders; pharmaceutical preparations, substances and biosimilars for the treatment of autoimmune and immune system, inflammatory, inflammatory bowel, gastrointestinal, musculoskeletal, dermatological, pulmonary, respiratory, oncological, and ophthalmic diseases and disorders; pharmaceutical preparations, substances and biosimilars used for the treatment of arthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, juvenile idiopathic arthritis, enthesitis related arthritis, osteoarthritis, peripheral spondyloarthritis, acute disc prolapse, inflammatory bowel disease, Crohn's disease, ulcerative colitis, Intestinal Behçet's Disease, chronic pouchitis, small bowel lesions, Hermansky-Pudlak syndrome, psoriasis, psoriasis vulgaris, psoriasis arthropica, plaque psoriasis, hidradenitis suppurativa, interstitial cystitis, sleep apnea, sarcoidosis, retinal vascular disorders, uveitis, choroidal neovascularization, Pyoderma Gangrenosum, giant cell arteritis, Netherton syndrome, anaplastic thyroid cancers, asthma, and refractory asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, December 15, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Trademark Events


Event DateEvent Description
Monday, November 23, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Saturday, November 21, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Sunday, May 10, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, May 10, 2020NON-FINAL ACTION E-MAILED
Sunday, May 10, 2020NON-FINAL ACTION WRITTEN
Saturday, May 9, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 8, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 8, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 27, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 27, 2019NON-FINAL ACTION E-MAILED
Friday, December 27, 2019NON-FINAL ACTION WRITTEN
Thursday, December 26, 2019ASSIGNED TO EXAMINER
Sunday, December 15, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, December 14, 2019NEW APPLICATION ENTERED IN TRAM